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Peft Ventricular Dyssynchrony Predicts Response and
rognosis After Cardiac Resynchronization Therapy
eroen J. Bax, MD, PHD,* Gabe B. Bleeker, MD,* Thomas H. Marwick, MD,†
ander G. Molhoek, MD, PHD,* Eric Boersma, PHD,‡ Paul Steendijk, MD, PHD,*
rnst E. van der Wall, MD, PHD,* Martin J. Schalij, MD, PHD*
eiden and Rotterdam, The Netherlands; and Brisbane, Australia
OBJECTIVES This study was designed to predict the response and prognosis after cardiac resynchronization
therapy (CRT) in patients with end-stage heart failure (HF).
BACKGROUND Cardiac resynchronization therapy improves HF symptoms, exercise capacity, and left
ventricular (LV) function. Because not all patients respond, preimplantation identification of
responders is needed. In the present study, response to CRT was predicted by the presence
of LV dyssynchrony assessed by tissue Doppler imaging. Moreover, the prognostic value of
LV dyssynchrony in patients undergoing CRT was assessed.
METHODS Eighty-five patients with end-stage HF, QRS duration 120 ms, and left bundle-branch
block were evaluated by tissue Doppler imaging before CRT. At baseline and six months
follow-up, New York Heart Association functional class, quality of life and 6-min walking
distance, LV volumes, and LV ejection fraction were determined. Events (death, hospital-
ization for decompensated HF) were obtained during one-year follow-up.
RESULTS Responders (74%) and nonresponders (26%) had comparable baseline characteristics, except
for a larger dyssynchrony in responders (87  49 ms vs. 35  20 ms, p  0.01).
Receiver-operator characteristic curve analysis demonstrated that an optimal cutoff value of 65
ms for LV dyssynchrony yielded a sensitivity and specificity of 80% to predict clinical
improvement and of 92% to predict LV reverse remodeling. Patients with dyssynchrony 65
ms had an excellent prognosis (6% event rate) after CRT as compared with a 50% event rate
in patients with dyssynchrony 65 ms (p  0.001).
CONCLUSIONS Patients with LV dyssynchrony 65 ms respond to CRT and have an excellent prognosis
after CRT. (J Am Coll Cardiol 2004;44:1834–40) © 2004 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.016Cardiology Foundation
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mardiac resynchronization therapy (CRT) has been pro-
osed as an adjunct therapy in patients with drug-refractory
eart failure (HF) (1–3). Initial studies demonstrated acute
mprovement in hemodynamics immediately after CRT (4).
ther studies have demonstrated the sustained clinical
enefit of CRT at longer follow-up, evidenced by improve-
ent in HF symptoms, quality of life, exercise capacity, and
eft ventricular (LV) systolic performance (1–3,5–7). How-
ver, it has also become clear that 20% to 30% of patients do
ot respond to CRT (1–3). Therefore, interest has shifted
oward identification of potential responders to CRT before
mplantation of the pacemaker (8–14). It is hypothesized
hat LV dyssynchrony is the most important determinant of
esponse to CRT, and various techniques to detect and
uantify LV dyssynchrony are currently under investigation
8–14). However, no large studies have focused on the
rediction of benefit from CRT based on the degree of LV
yssynchrony. More important, it is unclear whether pa-
ients with LV dyssynchrony who respond to CRT have a
etter prognosis than patients without dyssynchrony.
Accordingly, we have related the extent of LV dyssyn-
hrony before implantation of the CRT device (assessed
From the *Leiden University Medical Center, Leiden, The Netherlands;
University of Queensland, Brisbane, Australia; and ‡ThoraxCenter Rotterdam, The
etherlands.m
Manuscript received February 6, 2004; revised manuscript received August 2, 2004,
ccepted August 3, 2004.y tissue Doppler imaging [TDI]) to clinical outcome
nd LV reverse remodeling after CRT in 85 consecutive
atients. The accuracy of this approach (and the cutoff
alue for LV dyssynchrony) to predict outcome was
etermined using receiver-operating characteristic
ROC) curve analysis. Finally, the most important issue
as addressed: would identification of responders before
acemaker implantation translate to a favorable prognosis
uring follow-up?
ETHODS
atients and study protocol. Eighty-five consecutive pa-
ients with end-stage HF, scheduled for implantation of a
iventricular pacemaker, were included in the current study.
he patients were selected according to the established
election criteria for CRT: 1) severe HF (New York Heart
ssociation [NYHA] functional class III or IV), 2) severely
epressed LV ejection fraction (LVEF35%), and 3) QRS
xhibiting left bundle branch block configuration with a
uration 120 ms (1–3). Patients with atrial fibrillation or
ith a previously implanted pacemaker were excluded.
The study protocol was as follows: before pacemaker
mplantation, resting two-dimensional (2D) and color
oppler transthoracic echocardiography were performed to
easure LVEF and LV volumes and analyze the severity of
itral regurgitation (MR). Next, myocardial TDI was
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yssynchrony.
Clinical status was assessed at baseline and six months
ollow-up, including assessment of NYHA functional class,
uality of life (using the Minnesota Living with Heart
ailure questionnaire) (15), and evaluation of exercise ca-
acity using the 6-min walking test (16). At six months
ollow-up, LVEF and LV volumes and severity of MR were
eassessed by echocardiography; LV dyssynchrony was also
eassessed.
Hospitalization for HF and survival were assessed during
ne-year follow-up after pacemaker implantation.
chocardiography and data acquisition/analysis. Pa-
ients were imaged in the left lateral decubitus position
sing a commercially available system (Vivid Seven; General
lectric-Vingmed, Milwaukee, Wisconsin). Images were
btained using a 3.5-MHz transducer, at a depth of 16 cm
n the parasternal and apical views (standard long-axis,
wo-chamber and four-chamber images). Standard 2D and
olor Doppler data (3 consecutive beats), triggered to the
RS complex, were saved in cineloop format. For TDI,
olor Doppler frame rates varied between 100 and
20 frames/s depending on the sector width of the range of
nterest, and pulse repetition frequencies between 500 Hz to
KHz, resulting in aliasing velocities between 16 and
2 cm/s. Tissue Doppler parameters were measured from
olor images by offline analysis.
The LV volumes and the LVEF were calculated from the
pical two- and four-chamber images using the biplane
impson’s rule (17). The severity of MR was graded
emiquantitatively from color-flow Doppler in the conven-
ional parasternal long-axis and apical four-chamber images.
itral regurgitation was characterized as: mild  1 (jet
rea/left atrial area 10%), moderate  2 (jet area/left
trial area 10% to 20%), moderately severe  3 (jet
rea/left atrial area 20% to 45%), and severe  4 (jet
rea/left atrial area 45%) (18).
For TDI analysis, the digital cineloops were analyzed
sing commercial software (Echopac 6.1, General Electric-
ingmed) by two independent observers blinded to the
linical outcome. The sample volume was placed in the LV
asal portions of the anterior, inferior, septal, and lateral
Abbreviations and Acronyms
CRT  cardiac resynchronization therapy
HF  heart failure
LV  left ventricular
LVEF  left ventricular ejection fraction
MR  mitral regurgitation
NYHA  New York Heart Association
ROC  receiver-operating characteristic
RV  right ventricular
TDI  tissue Doppler imaging
2D  two-dimensionalalls (using the two- and four-chamber images) and, peregion, the time interval between the onset of the QRS
omplex and the peak systolic velocity was derived. Left
entricular dyssynchrony was defined as the maximum delay
etween peak systolic velocities among the four walls within
he LV (most frequently observed between the interventric-
lar septum and the lateral wall) (19). Interventricular
yssynchrony was assessed by comparing the delay between
eak systolic velocity of the right ventricular (RV) free wall
nd the LV lateral wall (8). The time required to analyze the
issue Doppler data was 10 to 15 min.
acemaker implantation. The LV pacing lead was in-
erted transvenously via the subclavian route. First, a coro-
ary sinus venogram was obtained using the balloon cath-
ter. Next, the LV pacing lead was inserted via the coronary
inus using an 8-F guiding catheter and positioned prefer-
bly in a (postero-)lateral vein (82 patients, 96%). In the
emaining three patients, the LV lead was positioned in the
nterior position.
The right atrial and ventricular leads (with separate
onnectors) were positioned conventionally. The atrioven-
ricular delay was optimized by 2D echocardiography so that
t provided the longest filling time for completion of the
nd-diastolic filling flow before LV contraction (20). A
edicated resynchronization device was used in all patients.
hen a conventional indication for an ICD existed, a
ombined device was implanted.
tatistical analysis. Results are presented as mean values
D. Data were compared using paired or unpaired Student
test when appropriate. Proportions were compared using
hi-square analysis with Yates correction. Optimal cutoff
alues of parameters to predict response to CRT were
etermined by ROC curve analysis. The optimal cutoff
alue was defined as that providing the maximal accuracy to
istinguish between responders/nonresponders.
Differences in cardiac event rates (death and hospitaliza-
ion for HF) over time were analyzed by the method of
aplan-Meier and log-rank test. For all tests, a p value
0.05 was considered significant.
ESULTS
tudy population. Eighty-five patients were included. The
atient characteristics are summarized in Table 1. Patients
ad severe LV dysfunction (mean LVEF 23  7%, range
% to 34%), with extensive dilation (LV end-diastolic
olume 258  56 ml). Approximately equal numbers of
atients had HF of ischemic and nonischemic etiology. The
RS duration was prolonged, ranging from 120 to 240 ms.
The mean LV dyssynchrony was 73  49 ms (range 0 to
21 ms) before CRT. The site of latest activation was the
ateral wall in 89% of patients; in the remaining 11%, the
ite of latest activation was the septum (n 4, although this
ay also be due to passive motion rather than true late
ctivation), anterior wall (n  2), or the inferior wall (n 
). The mean RV-LV dyssynchrony was 47  38 ms.
Thirty-seven patients received a resynchronization pace-
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r InSync III [n  10], Medtronic Inc., St. Paul, Minne-
ota) and 48 for a combined CRT-ICD device (Contak CD
n  15] or Contak Renewal [n  30], Guidant, Minne-
ota, and InSync III CD [n  3], Medtronic Inc., Minne-
ota). Two types of LV leads were used (Easytrack 4512-80
n  73], Guidant, Minnesota, or Attain-SD 4189 [n 
2], Medtronic Inc., Minnesota). The procedure was suc-
essful in all patients and no procedure-related complica-
ions were observed.
After CRT, the QRS duration was reduced from 178 
6 ms to 155  22 ms (p  0.01). The optimized
trioventricular delay was 115  32 ms.
Within six months after CRT, five patients died of
able 1. Patient Characteristics (n  85)
ge (yrs) 66 12
ender (M/F) 64/21
revious MI 39 (46%)
YHA functional class
III n  68
IV n  17
tiology
Ischemic 47 (55%)
Idiopathic 38 (45%)
RS (ms) 178 36
VEF (%) 23 7
VEDV (ml) 258 56
VESV (ml) 200 53
evere MR 21 (25%)
edication
Diuretics 83 (98%)
ACE inhibitors 81 (95%)
Spironolactone 46 (54%)
Beta-blockers 71 (84%)
Amiodarone 35 (41%)
CE  angiotensin-converting enzyme; LVEF  left ventricular ejection fraction;
VEDV  left ventricular end-diastolic volume; LVESV  left ventricular end-
ystolic volume; MI  myocardial infarction; MR  mitral regurgitation; NYHA 
ew York Heart Association.
Table 2. Baseline Characteristics of Responder
Respon
(n 
Age (yrs) 64
Gender (M/F) 46/1
Previous MI 27 (46
NYHA functional class III/IV 81%/2
Etiology
Ischemic 33 (56
Idiopathic 26 (44
QRS (ms) 174
6-MWT 291
QoL score 40
LVEF (%) 23
LVEDV (ml) 254
LVESV (ml) 197
Severe MR 12 (20
RV-LV dyssynchrony (ms) 47
LV dyssynchrony (ms) 876-MWT  6-minute walk test; QoL  quality of life; RV-LV 
Table 1.orsening HF. Because these patients did not have the
ix-month follow-up assessment, they could not be included
n the prediction of response to CRT, but they were
ncluded in the prognostic evaluation.
linical improvement after CRT. At baseline and six
onths follow-up, the clinical status of the patients was
ssessed. New York Heart Association functional class
mproved from 3.2  0.4 to 2.1  0.7 (p  0.01). In
ddition, the Minnesota score decreased from 42  16 to
9  16 (p  0.01), and the 6-min walking distance
ncreased from 278  132 m to 399  149 m (p  0.01).
he LVEF demonstrated a modest improvement (from
3  7% to 28  8%, p  0.05), with a reduction in LV
nd-diastolic volume (259  57 ml to 237  58 ml, p 
.05) and end-systolic volume (201  54 ml to 173  53
l, p 0.05). Mitral regurgitation improved by at least one
rade in 12 of 19 (63%) patients with severe regurgitation (2
atients of the 21 patients with severe MR at baseline died
efore echocardiographic follow-up).
esponders and nonresponders. The patients were sub-
equently divided into responders and nonresponders, based
n an improvement in NYHA functional class by 1 score
nd an improvement by 25% in 6-min walking distance
Tables 2 and 3). In the responders, the mean NYHA
unctional class improved from 3.2  0.4 to 1.7  0.5,
hereas it remained unchanged in the nonresponders (by
efinition). The 6-min walking distance improved from
91  122 m to 438  116 m and remained unchanged in
he nonresponders (279  155 m vs. 254  175 m) (by
efinition).
At baseline, no significant differences were observed
etween responders and nonresponders, except that the
onresponders tended to have larger LV end-diastolic and
nd-systolic volumes, although these differences were not
ignificant (Table 2). The only variable that was signifi-
antly different between the two groups was the LV dys-
 59) Versus Nonresponders (n  21)
Nonresponders
(n  21) p Value
66  12 NS
14/7 NS
9 (43%) NS
90%/10% NS
11 (52%) NS
10 (48%) NS
171  26 NS
279  155 NS
43  16 NS
22  8 NS
272  55 NS
214  55 NS
7 (33%) NS
49  29 NS
35  20 0.01s (n
ders
59)
9
3
)
9%
%)
%)
29
122
15
6
57
55
%)
34
49right ventricular-left ventricular; other abbreviations as in
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November 2, 2004:1834–40 LV Dyssynchrony Predicts Benefit From CRTynchrony, which was extensive in the responders and
inimal in the nonresponders (Table 2). Of note, RV–LV
yssynchrony was not different between responders and
onresponders.
The responders showed a significant improvement in
linical parameters after CRT (Table 3), whereas none of
he clinical parameters improved in the nonresponders after
RT. Furthermore, the LVEF improved in the responders
nd reverse remodeling was observed after CRT. In the
onresponders, the LVEF did not improve and the LV
olumes did not decrease after CRT.
In the responders, 12 patients had severe MR and 11
92%) patients improved in MR by at least one grade after
RT. In the nonresponders, seven patients had severe MR,
nd only one (14%, p  0.05 vs. responders) improved at
east one grade after CRT.
In responders, the LV dyssynchrony had decreased from
7  49 ms to 21  28 ms (p  0.01), whereas in the
onresponders, the LV dyssynchrony tended to increase,
lthough the difference was not significant (35  20 ms vs.
2  23 ms, p  NS).
rediction of response. The only variable at baseline that
as significantly different between responders and non-
esponders was the LV dyssynchrony. To define the
ptimal cutoff value to predict clinical response, ROC
urve analysis was performed. When responders were
efined as patients exhibiting an improvement in NYHA
able 3. Responders (n  59) Versus Nonresponders (n  21),
linical and Echocardiographic Variables Before and After Six
onths CRT
Responders
(n  59)
Nonresponders
(n  21)
p
Value
YHA functional class
Baseline 3.2  0.4 3.3  0.2
Follow-up 1.7  0.5† 3.1  0.3 0.01
-MWT (m)
Baseline 291  122 279  155 NS
Follow-up 438  116 254  175 0.01
RS (ms)
Baseline 174  29 171  26 NS
Follow-up 142  27* 165  31 0.01
oL score
Baseline 40  15 43  16 NS
Follow-up 24  12* 44  17 0.01
VEF (%)
Baseline 23  6 22  8 NS
Follow-up 29  8* 23  9 0.05
VEDV (ml)
Baseline 254  57 272  55 NS
Follow-up 225  53* 271  60 0.01
VESV (ml)
Baseline 197  55 214  55 NS
Follow-up 160  46* 211  56 0.01
evere MR
Baseline 12 (20%) 7 (33%) NS
Follow-up 1 (2%)* 6 (29%) 0.05
p  0.05 follow-up vs. baseline value; †by definition.
Abbreviations as in Tables 1 and 2.unctional class 1 score and an improvement 25% in
m
d-min walking distance, an optimal sensitivity and spec-
ficity of 80% were obtained at a cutoff level of 65 ms for
V dyssynchrony (Fig. 1).
Receiver-operating characteristic curve analysis was also
erformed to define the optimal cutoff value for LV dys-
ynchrony to predict reverse LV remodeling. At a cutoff
alue of 65 ms for LV dyssynchrony a sensitivity and
pecificity of 92% were obtained to predict a reduction of
15% LV end-systolic volume (Fig. 2).
The continuous relation between the LV dyssynchrony
nd the reduction in LV end-systolic volume is displayed in
igure 3. A linear relation existed between the LV dyssyn-
hrony and the reduction in LV end-systolic volume until
he LV dyssynchrony reached 100 ms. After this point, even
igure 1. Receiver-operating characteristic curve analysis demonstrated a
ensitivity and specificity of 80% to predict response to cardiac resynchro-
ization therapy defined as an improvement in New York Heart Associ-
tion functional class 1 score and an improvement 25% in 6-min
alking distance) at a cutoff level of 65 ms for left ventricular (LV)
yssynchrony.
igure 2. Receiver-operating characteristic curve analysis demonstrated a
ensitivity and specificity of 92% to predict reverse left ventricular (LV)
emodeling after cardiac resynchronization therapy defined as an improve-
ent in LV end-systolic volume 15%) at a cutoff level of 65 ms for LV
yssynchrony.
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LV Dyssynchrony Predicts Benefit From CRT November 2, 2004:1834–40f LV dyssynchrony increased further, no further reduction
n LV end-systolic volume occurred (as evidenced by the
orizontal line, y  55) (Fig. 3).
rediction of prognosis. Follow-up was performed during
ne year after implantation. A total of 16 events occurred in
he 80 patients, including 7 deaths (1 noncardiac death, 6
orsening HF) and 9 hospitalizations for decompensated
F. The event rate in responders was significantly lower
han in nonresponders (8% vs. 52%, p  0.01).
Moreover, when patients were divided according to the
resence/absence of LV dyssynchrony (using a 65 ms cutoff
alue), only three events (6%) occurred in the 49 patients
ith dyssynchrony as compared with 13 (33%) in the 31
atients without dyssynchrony. None of the five patients
ho died before the six-month follow-up assessment had
V dyssynchrony; inclusion of these patients resulted in a
0% event rate during the one-year follow-up in the patients
ithout dyssynchrony (Fig. 4).
Moreover, 6 of 48 (13%) patients with a combined
RT-ICD device experienced adequate shocks (for ventric-
lar arrhythmias) during the one-year follow-up; all of these
atients were nonresponders.
ISCUSSION
he findings in the current study can be summarized as
ollows: 1) all baseline characteristics are comparable in
esponders and nonresponders to CRT, except for the LV
yssynchrony, which was larger in responders; 2) baseline
V dyssynchrony of 65 ms or more has a sensitivity and
pecificity of 80% to predict clinical response and 92% to
redict reverse LV remodeling; 3) patients with extensive
yssynchrony who undergo CRT have an excellent progno-
is (6% event rate), whereas patients who do not have
yssynchrony and undergo CRT have a poor prognosis
event rate 50%).
enefit of CRT. In the entire study population, an improve-
igure 3. A linear relation existed between the extent of left ventricular (LV)
yssynchrony and the change in LV end-systolic volume (ESV) after cardiac
esynchronization therapy. However, LV dyssynchrony over 100 ms did not
esult in further reduction in LV end-systolic volume.ent in all clinical parameters was observed, in line with wrevious studies concerning CRT (5–7). Comparable to recent
andomized clinical trials (Multicenter InSync Randomized
linical Evaluation [MIRACLE], Multisite Stimulation in
ardiomyopathies Study [MUSTIC], Pacing Therapies for
ongestive Heart Failure [PATH-CHF]), reductions in
YHA functional class and quality of life score were noted and
n increase in 6-min walking distance was observed (5–7).
oreover, in the present study a modest improvement in
VEF was shown, comparable to results of the MIRACLE
rial (6). In addition, significant reverse remodeling was dem-
nstrated, also in line with data from the MIRACLE trial
21).
However, not all patients responded equally to CRT, and
hen patients were divided into responders and nonre-
ponders, based on improvement in NYHA functional class,
t became evident that an improvement in clinical parame-
ers was observed only in the responders. Moreover, im-
rovements in LVEF and reverse remodeling were also
bserved only in the responders. When individual results
ere analyzed, it became clear that 21 patients (26%) did
ot respond to CRT. When the five patients who died
efore the six-month follow-up were also included, the
ercentage of nonresponders was 31%. This observation is
n agreement with previous studies (8–14). For example, in
he MIRACLE trial, 20% of patients did not experience an
mprovement in symptoms and 32% did not improve in
YHA functional class (6). Similarly, Reuter et al. (22)
emonstrated that 18% of 102 consecutive patients under-
oing CRT did not improve in NYHA functional class and
uality-of-life score.
In the current study and in most of the large clinical trials,
he selection criteria included severe HF (NYHA functional
lass III or IV) with severely depressed LVEF (35%), and
igure 4. Cardiac events (cardiac death, hospitalization for decompensated
eart failure) during one-year follow-up after cardiac resynchronization
herapy. Patients with left ventricular (LV) dyssynchrony 65 ms had a
ignificantly lower event rate after cardiac resynchronization therapy as
ompared with patients with dyssynchrony 65 ms (6% vs. 50%, p 
.001).ide QRS complex (120 ms). Thus, additional selection
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November 2, 2004:1834–40 LV Dyssynchrony Predicts Benefit From CRTriteria are needed to reduce the high number of nonre-
ponders.
eft ventricular dyssynchrony to select candidates for
RT. When baseline characteristics were compared be-
ween responders and nonresponders (Table 2), the only
ariable that was different between the two groups was the
V dyssynchrony (whereas the RV-LV dyssynchrony was
lso not different). This finding was not unexpected, as
arious studies have recently emphasized the importance of
V dyssynchrony for the response to CRT (8–14). Pitzalis
t al. (23) have used M-mode echocardiography to assess
V dyssynchrony by measuring the septal-to-posterior wall
otion delay. Although this is an elegant and simple
ethod to assess LV dyssynchrony, in patients with isch-
mic heart disease and previous anterior infarction assess-
ent of septal movement is frequently not possible. Recent
tudies have therefore focused on TDI applications to assess
yssynchrony. Sogaard et al. (10) have used tissue tracking
n 25 patients to detect regions with delayed longitudinal
ontraction. The authors demonstrated that the extent of
elayed longitudinal contraction predicted response to
RT. Breithardt et al. (11) used strain rate imaging in 18
atients to assess dyssynchrony. More recent studies have
ocused on timing of peak systolic velocities of different
yocardial regions to assess LV dyssynchrony. Yu et al. (12)
ave evaluated 30 patients before and after CRT with TDI
nd demonstrated that LV dyssynchrony allowed separation
etween patients with and without LV remodeling as
xpressed by a reduction in end-systolic volume by more
han 15%. Assessment of dyssynchrony was comparable to
he present analysis, with the exception that 12 segments
ere used, instead of 4 segments in the present study.
Receiver-operating characteristic curve analysis demon-
trated a sensitivity and specificity of 80% for prediction of
linical status and 92% for the prediction of reverse LV
emodeling. Receiver-operating characteristic curve analysis
dentified the cutoff value of 65 ms as optimal. Of interest,
orcsan et al. (13) have recently evaluated a small group of
atients and also reported a similar value (65 ms) as optimal
utoff value to predict response to CRT. This cutoff level
ay now be used in further studies to prospectively select
atients for CRT.
rognostic value of CRT and LV dyssynchrony. The
ypical patients who are eligible for CRT (HF, depressed
VEF, and wide QRS complex) have a poor prognosis
hen treated conservatively (1–3). Moreover, Bader et al.
19) have recently shown that in these patients the presence
f LV dyssynchrony is an important predictor of poor
utcome.
Prognostic studies in patients undergoing CRT are still
carce. Various studies have evaluated patients after CRT;
he initial studies have reported the acute benefit (4), other
tudies have demonstrated response after six months to one
ear, and preliminary data have shown sustained benefit
ver time (5–7). A recent meta-analysis of the 11 published
tudies of 4 randomized trials (including 1,634 patients)emonstrated a short-term (six-month) survival benefit after
RT as compared with optimized medical therapy (24).
However, none of the studies have evaluated the relation
etween baseline dyssynchrony in patients undergoing CRT
nd prognosis. In the current study, one-year follow-up was
btained and the results demonstrated a low event rate (6%)
fter CRT in patients with LV dyssynchrony at baseline as
ompared with patients without dyssynchrony (50% event
ate). This observation further supports the hypothesis that
he degree of LV dyssynchrony is not only predictive of
esponse to CRT but is also related to favorable prognosis
hen treated by CRT.
It is most likely that both patients with and without LV
yssynchrony have a poor prognosis if untreated, and
ossibly the patients with LV dyssynchrony have an even
orse prognosis. If treated by CRT, the hemodynamic
mprovements observed after CRT in responders (i.e., the
atients with LV dyssynchrony) may result in an improved
rognosis, as observed in the current study. The patients
ithout LV dyssynchrony do not improve in hemodynam-
cs, resulting in poor long-term survival.
onclusions. Patients with extensive LV dyssynchrony
esponded well to CRT. Using a cutoff level of 65 ms, a
ensitivity and specificity of 80% were obtained to predict
linical response and of 92% to predict reverse LV remod-
ling. Moreover, patients with LV dyssynchrony 65 ms
ad an excellent prognosis after CRT, in contrast to patients
ith 65 ms who had a high event rate (50%) during
ne-year follow-up.
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